Therapeutic anti-methamphetamine antibody fragment-nanoparticle conjugates: synthesis and in vitro characterization.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioconjugate chemistry

• Publication date

  2012-08-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC300204NPMID 22873701PMCID PMC3463141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanocarriers as an Emerging Platform for Cancer Therapy

  2020cited by this paper
• The molar hydrodynamic volume changes of factor VIIa due to GlycoPEGylation.

  2011cited by this paper
• Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

  2009cited by this paper
• Uses of Nanoparticles for Central Nervous System Imaging and Therapy

  2009cited by this paper
• Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse—Methamphetamine and 3,4‐methylenedioxymethamphetamine

  2009cited by this paper
• Designing immunotherapies to thwart drug abuse.

  2009cited by this paper
• Development and Preclinical Testing of a High-Affinity Single-Chain Antibody against (+)-Methamphetamine

  2008cited by this paper
• Nanoparticles in Medicine: Therapeutic Applications and Developments

  2008cited by this paper
• Disulfide bridge based PEGylation of proteins.

  2008cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine Abuse

  2007cited by this paper
• FcRn: the neonatal Fc receptor comes of age

  2007cited by this paper
• Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells

  2007cited by this paper
• Synthesis and biosensor performance of a near-IR thiol-reactive fluorophore based on benzothiazolium squaraine.

  2007cited by this paper
• PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5

  2006cited by this paper
• Dendrimers in biomedical applications--reflections on the field.

  2005cited by this paper
• Polyacrylamide gel electrophoresis separation and detection of polyamidoamine dendrimers possessing various cores and terminal groups.

  2005cited by this paper
• Dendrimers in drug research.

  2004cited by this paper
• Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat

  2004cited by this paper
• Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation.

  2003cited by this paper
• Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.

  2003cited by this paper
• Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.

  2003cited by this paper
• Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery

  2002cited by this paper
• PEGylated antibodies and antibody fragments for improved therapy: a review.

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

  2000cited by this paper
• Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds.

  1999cited by this paper
• Amphetamine and its analogs : psychopharmacology, toxicology, and abuse

  1994cited by this paper
• Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1992cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• The Role of Dendrimers in Improving Antibody and Peptide Biologics for Cancer Treatment.

  2025cites this paper
• New Technologies Bloom Together for Bettering Cancer Drug Conjugates

  2022cites this paper
• New Technologies Bloom Together for Bettering Cancer Drug Conjugates

  2022cites this paper
• Dendrimers as Antiamyloid Agents

  2022cites this paper
• Facile Preparation of PNA-Peptide Conjugates with a Polar Maleimide-Thioether Linkage.

  2020cites this paper
• Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.

  2019cites this paper
• Bovine serum albumin stabilized iron oxide and gold bimetallic heterodimers: Synthesis, characterization and Stereological study

  2019cites this paper
• Polymer–drug conjugate therapeutics: advances, insights and prospects

  2018cites this paper
• Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)

  2016cites this paper
• Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry

  2016cites this paper
• PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance

  2016influential citation
• Dendrimer-Linked Antifreeze Proteins Have Superior Activity and Thermal Recovery.

  2015cites this paper
• A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments

  2015cites this paper
• Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.

  2014cites this paper
• Polymer-antibody fragment conjugates for biomedical applications

  2014cites this paper
• Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering

  2014cites this paper
• Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites

  2013cites this paper